Human genetic information is packaged into discrete bundles (chromosomes) that have protective caps on their ends, known as ‘telomeres’. The integrity of telomeres is vitally important for cells to continue to divide. A subset of inherited Bone Marrow Failure Syndromes, known as Telomere Biology Disorders, are caused by mutations in genes that are responsible for protecting telomeres. In these patients, degraded telomeres lead to the premature death of cells in the bone marrow, resulting in bone marrow failure.
The goal of this study is to use the latest developments in gene editing of human bone marrow cells to establish a mouse model that closely mimics the disease process in human Telomere Biology Disorders. This model will be used for determining how particular patient mutations cause disease, thus providing a more precise molecular diagnosis for patients and their families, and for creation of a platform to test potential new gene therapy cures for this form of inherited bone marrow failure.
2018-2021 (Grant-in-Aid): Identifying therapeutics which can be repurposed for the treatment of Myelodysplastic Syndromes and other bone marrow failure disorders. Associate Professor Amee George, The Australian National University. There are ...
Read more2017 – 2019 Fellowship / 2017 Grant-in-Aid, Towards targeted treatments for Fanconi Anaemia, Associate Professor Wayne Crismani, St Vincents Institute for Medical Research Fanconi Anaemia is an inherited disorder which can lead to bone ...
Read more2018-2020 (Grant-in-Aid): Predicting malignant transformation of Bone Marrow Failure Syndromes using longitudinal targeted sequencing of peripheral blood and cell-free DNA (cfDNA). Associate Professor Piers Blombery, Peter MacCallum Cancer ...
Read more2018-2020 (Grant in aid): Influences of clonal haematopoiesis in allogeneic bone marrow transplantation. Dr Paul Yeh and Professor Mark Dawson, The University of Melbourne. Dr Paul Yeh’s research focusses on using genetic testing to study clonal ...
Read more